Empirical-colistin inhalation improves ventilatory parameters and severity scoring in VAP caused by Gram-negative bacteria
Ventilator-associated pneumonia (VAP) is accompanied with serious complications. The current study assessed the impact of adjuvant nebulized colistin on the outcomes of VAP patients. The study was a prospectively randomized clinical controlled trial done at the international medical center, Cairo, E...
Main Authors: | Nourhan Abu-Thuraya, Lamia El wakeel, Mohamed Elghoemi, Alia Abdelfattah |
---|---|
Format: | Article |
Language: | English |
Published: |
Ain Shams University
2022-06-01
|
Series: | Archives of Pharmaceutical Sciences Ain Shams University |
Subjects: | |
Online Access: | https://aps.journals.ekb.eg/article_246919.html |
Similar Items
-
Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible <i>Acinetobacter baumannii</i> VAP: Clinical, Pharmacokinetic and Microbiome Features
by: Gennaro De Pascale, et al.
Published: (2023-01-01) -
Evaluating the Efficacy of Inhaled Colistin via Two Nebulizer Types in Ventilator-Associated Pneumonia: Prospective Randomized Trial
by: Chung-Chi Huang, et al.
Published: (2024-11-01) -
Randomized control study of nebulized colistin as an adjunctive therapy in ventilator-associated pneumonia in pediatric postoperative cardiac surgical population
by: K S Bharathi, et al.
Published: (2022-01-01) -
Nebulized Colistin in Ventilator-Associated Pneumonia and Tracheobronchitis: Historical Background, Pharmacokinetics and Perspectives
by: Yinggang Zhu, et al.
Published: (2021-05-01) -
The effectiveness of colistin/levofloxacin compared to colistin/meropenem in the treatment of ventilator-associated pneumonia (VAP) caused by carbapenem-resistant Acinetobacter baumannii: a randomized controlled clinical trial
by: Mahnaz Momenzadeh, et al.
Published: (2023-01-01)